Effect of surgical intervention on the expression of leukemia inhibitory factor and L-selectin ligand in the endometrium of hydrosalpinx patients during the implantation window
- PMID: 23226768
- PMCID: PMC3494122
- DOI: 10.3892/etm.2012.728
Effect of surgical intervention on the expression of leukemia inhibitory factor and L-selectin ligand in the endometrium of hydrosalpinx patients during the implantation window
Abstract
The aim of this study was to investigate the effect of surgical intervention on the expression of leukemia inhibitory factor (LIF) and L-selectin ligand in the endometrium of patients with hydrosalpinx during the implantation window. A total of 60 patients with hydrosalpinx and 30 patients with tubal obstruction were recruited, and immunohistochemistry was performed to detect the expression of LIF and L-selectin ligand in the endometrium of hydrosalpinx patients before and after surgery and in the endometrium of patients with tubal obstruction. The expression of LIF and L-selectin ligand in the endometrium of hydrosalpinx patients before surgery was markedly lower than that of patients with tubal obstruction (P<0.05). Following surgery, the expression of LIF and L-selectin ligand in the endometrium of hydrosalpinx patients was comparable to that of patients with tubal obstruction (P>0.05). In addition, there was a pronounced difference in the expression of LIF and L-selectin ligand in the endometrium before and after surgery in patients with hydrosalpinx (P<0.05). Hydrosalpinx reduces the expression of LIF and L-selectin ligand in the endometrium during the implantation window. LIF and L-selectin ligand may be important factors influencing the endometrial receptivity of hydrosalpinx patients, and surgery is capable of improving the expression of LIF and L-selectin ligand in the endometrium during the implantation window.
Figures

Similar articles
-
Surgical treatment for hydrosalpinx increases the expression of integrin αvβ3 in the endometrium during the implantation window.Exp Ther Med. 2012 Sep;4(3):415-418. doi: 10.3892/etm.2012.610. Epub 2012 Jun 14. Exp Ther Med. 2012. PMID: 23181110 Free PMC article.
-
Expression of alpha 1 and beta 3 integrins subunits in the endometrium of patients with tubal phimosis or hydrosalpinx.Fertil Steril. 2006 Jan;85(1):188-92. doi: 10.1016/j.fertnstert.2005.06.039. Fertil Steril. 2006. PMID: 16412752
-
Decreased Endometrial Expression of Leukemia Inhibitory Factor Receptor Disrupts the STAT3 Signaling in Adenomyosis During the Implantation Window.Reprod Sci. 2017 Aug;24(8):1176-1186. doi: 10.1177/1933719116681515. Epub 2016 Nov 30. Reprod Sci. 2017. PMID: 27903796
-
Leukemia inhibitory factor and human embryo implantation.Ann N Y Acad Sci. 2004 Dec;1034:176-83. doi: 10.1196/annals.1335.020. Ann N Y Acad Sci. 2004. PMID: 15731310 Review.
-
Hydrosalpinx and IVF: assessment of treatments implemented prior to IVF.Reprod Biomed Online. 2007 Feb;14(2):235-41. doi: 10.1016/s1472-6483(10)60792-4. Reprod Biomed Online. 2007. PMID: 17298728 Review.
References
-
- Lessey BA. Assessment of endometrial receptivity. Fertil Steril. 2011;96:522–529. - PubMed
-
- Taylor E, Gomel V. The uterus and fertility. Fertil Steril. 2008;89:1–16. - PubMed
-
- Mijatovic V, Veersema S, Emanuel MH, et al. Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy. Fertil Steril. 2010;93:1338–1342. - PubMed
-
- Seli E, Kayisli UA, Cakmak H, et al. Removal of hydrosalpinges increases endometrial leukaemia inhibitory factor (LIF) expression at the time of the implantation window. Hum Reprod. 2005;20:3012–3017. - PubMed
-
- Paiva P, Menkhorst E, Salamonsen L, Dimitriadis E. Leukemia inhibitory factor and interleukin-11: critical regulators in the establishment of pregnancy. Cytokine Growth Factor Rev. 2009;20:319–328. - PubMed
LinkOut - more resources
Full Text Sources